AOPs

OECD View API
Searches both title and fulltext content
Takes you to the requested AOP
Clear Search Terms Clears search terms and filters

Showing 426 to 450 of 548 AOPs

Clear Table Filters
ID Title Point of Contact License MIE AO OECD Status OECD Project
487 Unknown MIE altering cholesterol metabolism leading to decreased cognition Evgeniia Kazymova BY-SA 1114: Unknown, MIE 402: Cognitive function, decreased
488 Increased reactive oxygen species production leading to decreased cognitive function Cataia Ives BY-SA 1115: Increase, Reactive oxygen species 402: Cognitive function, decreased
489 Inhibition of voltage-gated sodium channels leading to decreased cognition Brendan Ferreri-Hanberry BY-SA 1353: Binding to voltage-gated sodium channel 402: Cognitive function, decreased
490 Co-activation of IP3R and RyR leads to reduced IQ through non-cholinergic mechanisms Arthur Author All rights reserved
491 Decrease, GLI1/2 target gene expression leads to orofacial clefting Agnes Aggy All rights reserved 2040: Decrease, GLI1/2 target gene expression 2042: Increase, Orofacial clefting Under Development 1.101
492 Glutathione conjugation leading to reproductive dysfunction via oxidative stress Allie Always All rights reserved 2131: Conjugation, GSH 406: decreased, Fertility
493 ERa inactivation alters AT expansion and functions and leads to insulin resistance and metabolically unhealthy obesity Evgeniia Kazymova All rights reserved 2126: Estrogen receptor alpha inactivation 2129: Metabolically unhealthy Obesity
494 AhR activation leading to liver fibrosis Cataia Ives BY-SA 18: Activation, AhR 344: N/A, Liver fibrosis
495 Androgen receptor activation leading to prostate cancer Brendan Ferreri-Hanberry All rights reserved 25: Agonism, Androgen receptor 2135: Prostate cancer
496 Androgen receptor agonism leading to reproduction dysfunction （in zebrafish） Arthur Author BY-SA 25: Agonism, Androgen receptor 442: Decreased, Population trajectory
497 ERa inactivation alters mitochondrial functions and insulin signalling in skeletal muscle and leads to insulin resistance and metabolic syndrome Agnes Aggy All rights reserved 2126: Estrogen receptor alpha inactivation
498 Increased LCN2/iron complex leading to neurological disorders Allie Always Open for adoption 2148: Increased LCN2/iron complex binds to SLC22A17 receptor in neuron 2150: Neurological disorder
499 Activation of MEK-ERK1/2 leads to deficits in learning and cognition via disrupted neurotransmitter release Evgeniia Kazymova All rights reserved 2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2 341: Impairment, Learning and memory
500 Activation of MEK-ERK1/2 leads to deficits in learning and cognition via ROS and apoptosis Cataia Ives All rights reserved 2146: Activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase 1/2 341: Impairment, Learning and memory
501 Excessive iron accumulation leading to neurological disorders Brendan Ferreri-Hanberry Open for adoption 2149: Increased intracelluar Iron accumulation 2150: Neurological disorder
502 Decrease, cholesterol synthesis leads to orofacial clefting Arthur Author All rights reserved None 2042: Increase, Orofacial clefting Under Development 1.101
503 Activation of uterine estrogen receptor-alfa leading to endometrial adenocarcinoma, via epigenetic modulation Agnes Aggy BY-SA 1065: Activation, estrogen receptor alpha 2154: Uterine adenocarcinoma (endometrioid adenocarcinoma Type I) Under Review 1.100
504 SULT1E1 inhibition leading to uterine adenocarcinoma via increased estrogen availability at target organ level Allie Always All rights reserved 2155: Inhibition of Sulfotransferase E1 (SULT1E1) 1065: Activation, estrogen receptor alpha
505 Reactive Oxygen Species (ROS) formation leads to cancer via inflammation pathway Evgeniia Kazymova BY-SA 1115: Increase, Reactive oxygen species 885: Increase, Cancer
506 Binding of Influenza A Virus (IAV) to Sialic Acid Glycan Receptor leads to viral infection proliferation Cataia Ives All rights reserved 2158: Influenza A Virus (IAV) binds sialic acid glycan receptor 2194: Influenza A Virus (IAV) shedding and transmission
507 Nrf2 inhibition leading to vascular disrupting effects via inflammation pathway Brendan Ferreri-Hanberry All rights reserved 1417: NFE2/Nrf2 repression 2161: Increase, Vascular disrupting effects
508 Nrf2 inhibition leading to vascular disrupting effects through activating HIF1α, Semaphorin 6A, and Dll4-Notch pathway Arthur Author All rights reserved 1417: NFE2/Nrf2 repression 2161: Increase, Vascular disrupting effects
509 Nrf2 inhibition leading to vascular disrupting effects through activating apoptosis signal pathway and mitochondrial dysfunction Agnes Aggy All rights reserved 1417: NFE2/Nrf2 repression 2161: Increase, Vascular disrupting effects
510 Demethylation of PPAR promotor leading to vascular disrupting effects Allie Always All rights reserved 228: peroxisome proliferator activated receptor promoter demethylation 2161: Increase, Vascular disrupting effects
511 The AOP framework on ROS-mediated oxidative stress induced vascular disrupting effects Evgeniia Kazymova All rights reserved 1115: Increase, Reactive oxygen species 2161: Increase, Vascular disrupting effects